Filter posts

The ‘Access to Medicines’ Debate: Throwing Patients Without Cures Under the Proverbial Bus

The vast majority of the world’s patients remain completely forgotten in the ‘access to medicines’ …

BIO Voices Agree: Intellectual Property Delivers

Over the last year, the U.S. Chamber of Commerce’s Global IP Center (GIPC) has met …

Novartis at India Supreme Court: Evergreening Myths and Patent Reality

Novartis will go before India’s Supreme Court on September 11, 2012 challenging the refusal by …

Seed Patents: How Innovation May Get Lost in the Grain Elevator

The Bowman v. Monsanto case currently on petition for a writ of certiorari to the …

Prior User Rights and Trade Secrets

By Joe Allen, President, Allen and Associates One theme of the day is the cloud …

Patent-Eligible Subject Matter after Mayo v. Prometheus: Exploring the Path Forward

Patent-Eligible Subject Matter after Mayo v. Prometheus: Exploring the Path Forward is a public round-table event hosted …

American Invents Act Strategies Highlighted at the IPCC Conference

By David Saravitz, Alston + Bird Day 2 of the 2012 BIO Intellectual Property Counsels’ Committee …

Biotech Patent Case Law Updates at the IPCC

By John W. Cox, Counsel at Alston+Bird LLP The Spring 2012 BIO Intellectual Property Counsels’ Committee …

Congressional Hearing on International Patent Issues: BIO Submits Comments

The House Judiciary Committee conducted a hearing on World IP Day on “International Patent Issues: …

BIO Convention 2012: Biotech IP and Tech Transfer Sessions

Recent court decisions and ongoing implementation of the America Invents Act are certain to impact …